Journal Home
Search for

Volume 6, Issue 8, Pages 3178-3186 (August 2010)


View previous. 37 of 57 View next.

Synthesis and characterization of poly(methyl methacrylate)-based experimental bone cements reinforced with TiO2–SrO nanotubes

S.M.Z. Khaleda, Paul A. Charpentiera, Amin S. RizkallaabCorresponding Author Informationemail address

Received 1 December 2009; received in revised form 9 February 2010; accepted 12 February 2010. published online 18 February 2010.

Abstract 

In an attempt to overcome existing limitations of experimental bone cements we here demonstrate a simple approach to synthesizing strontium-modified titania nanotubes (n-SrO–TiO2 tubes) and functionalize them using the bifunctional monomer methacrylic acid. Then, using ‘grafting from’ polymerization with methyl methacrylate, experimental bone cements were produced with excellent mechanical properties, radiopacity and biocompatibility. Transmission electron microscopy (TEM), scanning electron microscopy (SEM), energy-dispersive spectroscopy mapping and backscattered SEM micrographs revealed a uniform distribution of SrO throughout the titanium matrix, with retention of the nanotubular morphology. Nanocomposites were then reinforced with 1, 2, 4 and 6 wt.% of the functionalized metal oxide nanotubes. Under the mixing and dispersion regime employed in this study, 2 wt.% appeared optimal, exhibiting a more uniform dispersion and stronger adhesion of the nanotubes in the poly(methyl methacrylate) matrix, as shown by TEM and SEM. Moreover, this optimum loading provided a significant increase in the fracture toughness (KIC) (20%) and flexural strength (40%) in comparison with the control matrix (unfilled) at P<0.05. Examination of the fracture surfaces by SEM showed that toughening was provided by the nanotubes interlocking with the acrylic matrix and crack bridging during fracture. On modifying the n-TiO2 tubes with strontium oxide the nanocomposites exhibited a similar radiopacity to a commercial bone cement (CMW® 1), while exhibiting a significant enhancement of osteoblast cell proliferation (242%) in vitro compared with the control at P<0.05.

a Department of Chemical and Biochemical Engineering, Faculty of Engineering, University of Western Ontario, London, Ontario, Canada N6A 5B9

b Division of Biomaterials Science, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada N6A 5B9

Corresponding Author InformationCorresponding author. Address. Biomaterials Science, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada N6A 5B9. Tel.: +1 519 661 2111x82212; fax: +1 519 661 3498.

PII: S1742-7061(10)00092-9

doi:10.1016/j.actbio.2010.02.024


View previous. 37 of 57 View next.